Literature DB >> 35864417

The Associations Between Alanine Aminotransferase and Other Biochemical Parameters in Lean PCOS.

Cai Liu1, Kai Liu2, Xiao Zhao3, Junhua Zhu1, Yang Liu1, Lina Hao1, Yanyun Gao1, Peng Liu4.   

Abstract

To explore the associations of alanine aminotransferase in lean women of polycystic ovary syndrome (PCOS) with other biochemical parameters and the potential risk factors. This is a retrospective cohort study with lean PCOS (n = 91) and healthy controls (n = 45); we reviewed the electrical records and databases of the PCOS patients in our infertility clinic between January 2019 and September 2021; independent t-test, linear correlation analysis, and multiple linear regression were used to explore the associations. Higher levels of luteinizing hormone, total testosterone, thyroid stimulating hormone, platelet count, lymphocyte count, homocysteine, alanine aminotransferase (ALT), and uric acid were identified in lean PCOS patients, while follicle-stimulating hormone level was lower in in lean PCOS as expected (P < 0.05). Of note, the linear correlation showed that BMI, total testosterone, white blood cell count, lymphocyte count, aspartate aminotransferase, and uric acid were positively associated with alanine aminotransferase (r = 0.232, 0.318, 0.218, 0.388, 0.602, 0.353 respectively, P < 0.05). After multiple linear regression was performed, total testosterone and aspartate aminotransferase were independently and positively correlated with alanine aminotransferase in lean PCOS (B = 0.251, 0.605 respectively, P < 0.05). Higher level of ALT was identified in the lean PCOS. BMI, white blood cell count, lymphocyte count, aspartate aminotransferase, uric acid, and total testosterone were positively correlated with ALT in lean PCOS. Total testosterone and aspartate aminotransferase were independently and positively associated with ALT in lean PCOS after multiple linear regression. There might exist a potential risk of afflicting liver impairment for the lean PCOS women in the earlier period. Early examination and intervention might be necessary to prevent or delay the progression of the liver disease as soon as the diagnosis of PCOS.
© 2022. The Author(s).

Entities:  

Keywords:  Alanine aminotransferase; Associations; Liver damage; Polycystic ovary syndrome; Total testosterone

Year:  2022        PMID: 35864417     DOI: 10.1007/s43032-022-01030-w

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  37 in total

Review 1.  The ovarian stroma as a new frontier.

Authors:  Hadrian M Kinnear; Claire E Tomaszewski; Faith L Chang; Molly B Moravek; Min Xu; Vasantha Padmanabhan; Ariella Shikanov
Journal:  Reproduction       Date:  2020-09       Impact factor: 3.906

Review 2.  Hepatic manifestations of women with polycystic ovary syndrome.

Authors:  Mei-Jou Chen; Hong-Nerng Ho
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2016-04-06       Impact factor: 5.237

3.  Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome.

Authors:  Mei-Jou Chen; Han-Mo Chiu; Chi-Ling Chen; Wei-Shiung Yang; Yu-Shih Yang; Hong-Nerng Ho
Journal:  J Clin Endocrinol Metab       Date:  2010-04-28       Impact factor: 5.958

Review 4.  Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy.

Authors:  Seema Patel
Journal:  J Steroid Biochem Mol Biol       Date:  2018-04-17       Impact factor: 4.292

5.  Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health.

Authors:  A E Joham; J A Boyle; S Ranasinha; S Zoungas; H J Teede
Journal:  Hum Reprod       Date:  2014-02-18       Impact factor: 6.918

Review 6.  Polycystic ovary syndrome.

Authors:  Ricardo Azziz; Enrico Carmina; ZiJiang Chen; Andrea Dunaif; Joop S E Laven; Richard S Legro; Daria Lizneva; Barbara Natterson-Horowtiz; Helena J Teede; Bulent O Yildiz
Journal:  Nat Rev Dis Primers       Date:  2016-08-11       Impact factor: 52.329

Review 7.  Polycystic Ovary Syndrome.

Authors:  Ricardo Azziz
Journal:  Obstet Gynecol       Date:  2018-08       Impact factor: 7.661

8.  Correlation of Subclinical Hypothyroidism With Polycystic Ovary Syndrome (PCOS).

Authors:  Murk Fatima; Sofia Amjad; Habiba Sharaf Ali; Tousif Ahmed; Shabnam Khan; Marvi Raza; Mahreen Inam
Journal:  Cureus       Date:  2020-05-15

Review 9.  Alanine aminotransferase-old biomarker and new concept: a review.

Authors:  Zhengtao Liu; Shuping Que; Jing Xu; Tao Peng
Journal:  Int J Med Sci       Date:  2014-06-26       Impact factor: 3.738

Review 10.  Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS).

Authors:  Svetlana Spremović Rađenović; Miljan Pupovac; Mladen Andjić; Jovan Bila; Svetlana Srećković; Aleksandra Gudović; Biljana Dragaš; Nebojša Radunović
Journal:  Biomedicines       Date:  2022-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.